Founded in 2004 and located in Zhongguancun Shunyi Park, Beijing O&D Biotech Co., Ltd. is a fast-growing high-tech enterprise with a strong expertise in the production, supply and development of in-vitro diagnostic instruments and reagents. As a pioneer dedicated to POCT, O&D Biotech has expanded its product portfolio into CyPath® TCT systems, Fluorescence Immunoassay analyzers, Chemiluminescence Immunoassay platforms and RUNP® diagnostic test kits for infectious diseases, cardiac abnormalities, diabetes, infection, hormone, cerebral injuries, gastrointestinal diseases and renal injuries.

O&D Biotech has been certified by ISO 13485 since 2012, and owns over 80 CFDA (NMPA) certificates and 123 CE certificates. RUNP® diagnostic test kits for cardiac markers have been awarded the certificate of conformity of inter-room quality assessment by the clinical examination center of China National Health Commission. The Fluorescence Immunoassay Analyzers are the recommended medical instruments for chest pain centers. Utilizing special technologies such as Semi-Liquid Phase Reaction, Immunochromatographic Assay and Red Nanofluorescent Microsphere, fluorescence immunoassay reagents have been widely used and won high reputation from customers.

COVID-19 Antigen Rapid Test has got CE approval, passed Germany and France’s registrations and entered the EU Common List. The product has been sold to countries around the world including Germany, Ireland, India, Thailand, Malaysia, Nigeria, Nepal and Cambodia.

Throughout the development and expansion process, O&D Biotech has built an ever-expanding, talented workforce from home and abroad and woven diligence, passion, resilience, and a can-do attitude into our cultural fabric, driving us to pursue the mission of "winning time for saving lives".